HLS Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 91
Employees
  • Stock Symbol
  • HLS
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $12.57
  • (As of Tuesday Closing)

HLS Therapeutics General Information

Description

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada and the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Distributors (Healthcare)
Drug Discovery
Stock Exchange
TSE
Primary Office
  • 10 Carlson Court
  • Suite 701, Etobicoke
  • Toronto, Ontario M9W 6L2
  • Canada
+1 (647) 000-0000

HLS Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HLS Therapeutics Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.57 $12.79 $12.42 - $17.49 $408M 32.5M 19.4K -$0.51

HLS Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 547,149 540,159 654,174 381,500
Revenue 60,804 56,109 54,160 61,415
EBITDA 23,671 22,872 19,161 20,346
Net Income (16,207) (15,331) (19,552) (24,806)
Total Assets 283,913 303,906 319,671 306,425
Total Debt 100,031 108,443 102,099 105,696
Public Fundamental Data provided by Morningstar, Inc. disclaimer

HLS Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HLS Therapeutics‘s full profile, request access.

Request a free trial

HLS Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of br
Pharmaceuticals
Toronto, Canada
91 As of 2020
00000
000000000 00000

00000

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
000000000000000
Lake Forest, IL
0000 As of 0000
0000000000.

00000000

im ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequa
0000000000000
Trevose, PA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HLS Therapeutics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Akorn Corporation Lake Forest, IL 0000 0000000000.
000000000000 00000 Corporate Backed or Acquired Trevose, PA 00 00000 000000&0 00000
000000 00000 Corporation Mumbai, India 0000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
00000000 Corporation Basel, Switzerland 000000 000000000000
You’re viewing 5 of 9 competitors. Get the full list »

HLS Therapeutics Executive Team (11)

Name Title Board Seat Contact Info
Gilbert Godin Co-Founder, Chief Executive Officer & Board Member
Tim Hendrickson Chief Financial Officer
David Spence Controller, Finance
Daniel Tassé Independent Director
Ryan Lennox JD Secretary, Administration & Senior Vice President
You’re viewing 5 of 11 executive team members. Get the full list »

HLS Therapeutics Board Members (10)

Name Representing Role Since
000000 00000000 Self Board Member 000 0000
0000000 00000 HLS Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
0000000 000000 HLS Therapeutics Co-Founder, Founding Chief Executive Officer & Board Member 000 0000
0. 00000000 HLS Therapeutics Board Member 000 0000
0000 0000000 00. Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

HLS Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HLS Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore HLS Therapeutics‘s full profile, request access.

Request a free trial

HLS Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 12-Mar-2018 0000000000 000.00 Holding Companies 0000000 0
To view HLS Therapeutics’s complete acquisitions history, request access »